Note: This article was updated July 21 to add recommendations on restarting biologics following COVID-19. On April 29, the ACR released Guidance for the Management of Adult Patients with Rheumatic Disease During the COVID‐19 Pandemic and later updated the guidance for publication in Arthritis & Rheumatology. The recommendations address various treatment options and provide general…
The ACR, CSRO and Arthritis Foundation asked the Centers for Medicare & Medicaid Services to review the decision to add Stelara to the Self-Administered Drugs list, which would limit access for patients who can’t self-administer.
The ACR has developed two new clinical guidance documents for pediatric patients in the context of the COVID-19 pandemic.
In light of the current COVID-19 pandemic, the ACR has dedicated a few episodes of the ACR on Air podcast to the challenges that have arisen, along with information about the available resources and guidance. The first episode in this special series looks at drug shortages surrounding hydroxychloroquine (HCQ) and its initial uses to treat…
The ACR has been working on many levels to assist the rheumatology community during the COVID-19 pandemic, and we are focusing our efforts on areas critical for rheumatologists and rheumatology professionals, practices and patients. Because the pandemic poses many clinical and economic challenges, the ACR will continue to monitor this fast-paced, ever-changing situation and provide…
Rheumatologists in community-based practices work closely with patients, which allows them to notice trends and nuances researchers may not. Unfortunately, few opportunities exist for rheumatologists to test their observations through research, in addition to taking care of patients. Limited funding, time constraints and competition from larger academic medical centers are some of the barriers that…
ACR Convergence 2020—the ACR’s annual meeting—will be presented online. Get ready for an innovative experience.
The American College of Rheumatology is deeply troubled by the recent events surrounding the death of George Floyd. This tragedy is the latest in a long history of senseless killings of people of color. We recognize that racial inequality is an invisible undercurrent impacting the lives of many of our members and patients, and we…
Despite efforts by the ACR and other organizations, Blue Cross Blue Shield of Tennessee has indicated that it will move forward with implementation of its specialty pharmacy acquisition mandate on July 1, 2020.
Top RheumPAC donors attended a virtual legislative update and Q&A with Rep. Ami Bera (D-Calif.) shortly after the release of House Democrats’ $3 trillion coronavirus response plan.